Ika Puspita Sari
Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Special Region of Yogyakarta, Indonesia; Academic Hospital of Universitas Gadjah Mada, Yogyakarta 55291, Special Region of Yogyakarta, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Suspected fentanyl–midazolam adverse drug reactions, mainly bradypnea and bradycardia, are associated with prolonged intensive care unit stay in mechanically ventilated patients Windy Septiyanti; Ika Puspita Sari; Tri Murti Andayani
Acta Pharmaciae Indonesia : Acta Pharm Indo Vol 14 No 1 (2026): Acta Pharmaciae Indonesia: Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.api.2026.14.1.18702

Abstract

Background: Fentanyl–midazolam remains a common analgosedation regimen for mechanically ventilated patients in many intensive care units (ICUs). Its adverse drug reactions (ADRs) may prolong ICU length of stay (LOS), but evidence is limited, particularly in Indonesia. Objective: To describe suspected ADRs associated with fentanyl–midazolam and their association with ICU LOS in mechanically ventilated patients. Methods: This retrospective cohort study reviewed records of adults receiving mechanical ventilation and continuous fentanyl–midazolam infusion in the ICU of an Indonesian academic hospital from January 2022 to April 2023. Of 460 patients screened, 80 were analyzed (40 with and 40 without suspected ADRs). Causality was assessed with the World Health Organization–Uppsala Monitoring Centre system and severity with the Hartwig scale. Prolonged LOS was defined as ≥3 days. Associations were tested with the chi-square test and expressed as risk ratios (RRs). Results: Among the 40 patients with suspected ADRs, the most frequent reactions were bradypnea (17/40, 42.5%), bradycardia (14/40, 35.0%), and apnea (4/40, 10.0%). Causality was probable in 27 patients (67.5%) and possible in 13 (32.5%), and 36 reactions (90.0%) were Hartwig level 1. Prolonged LOS occurred in 32 of 40 patients (80.0%) with ADRs and 22 of 40 (55.0%) without ADRs (p = 0.017; RR 1.45; 95% CI 1.06–2.00). Conclusion: Suspected fentanyl–midazolam ADRs, mostly mild respiratory depression and bradycardia, were associated with prolonged ICU stay. Close respiratory and hemodynamic monitoring and careful dose titration are warranted.